Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2000
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143759 Tetrazoles
11/07/2000US6143742 Treatment for necrotizing infections
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143309 Mixture with aprotic solvent; cosmetic
11/07/2000US6143287 Applying a mixture of liposome and phthalocyanine; applying light source
11/06/2000CA2308793A1 Composition containing at least one aromatic bicyclic compound and at least one lipophilic solar filter, and its uses
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064869A1 Vitamin d analogues and their pharmaceutical use
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064481A1 Controlled release of growth factors from heparin containing matrices
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064472A1 Methods and compositions for treating dermatological disorders with fruit extracts
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064450A1 Pharmaceutical composition
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064279A1 Cactus fruit health products
11/02/2000WO2000064278A1 Ginseng berry health products
11/02/2000WO2000064260A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000WO2000048554A3 Synergistic antimicrobial skin washing compositions
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000038626A3 Substrate composition and method of use for sequestration of skin irritants
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1048292A2 Stable combination of active agents containing surface-active gucose derivatives and hydroxycarboxylic acids
11/02/2000EP1048288A1 Use of halogenated antimycotic- and cationic antibacterial-compounds for the treatment of skin redness and/or cutaneous disorders induced by malassezia spp
11/02/2000EP1047732A1 Color shifting film glitter
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047676A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP1047411A1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047405A1 Self-foaming cleansing systems
11/02/2000EP1047398A1 Topical compositions containing whey proteins
11/02/2000EP1047397A1 Topical compositions for enhancing glutathione production
11/02/2000EP0626844B1 Compositions of clindamycin and benzoyl peroxide for acne treatment
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2371165A1 Vitamin d analogues and their pharmaceutical use
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371046A1 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369910A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000CA2369579A1 Controlled release of growth factors from heparin containing matrices
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/01/2000CN1272118A Collagen type I and type III adhesive compositions
11/01/2000CN1272043A Nutritional composition for treatment of pressure ulcers
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271724A (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent
11/01/2000CN1271587A Medicine for treating skin ulcer
11/01/2000CN1271570A Cosmetic composition containing pigment originated from pyrolopyrrole
11/01/2000CN1058014C New heterocyclic spiro compounds, process for preparation thereof, and pharmaceutical compositions containing them
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057928C Medicine for ulcer and its preparation
11/01/2000CN1057917C Medicine for treatment of alopecia and making method thereof
11/01/2000CN1057913C Yinchan emulsion
10/2000
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140317 Pyrrolopyrimidines and processes for their preparation
10/31/2000US6140307 Pharmaceutical composition
10/31/2000US6139844 Method for treating or eliminating a parasitic disease
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063246A2 Compounds and methods for modulating beta-catenin mediated gene expression
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063198A1 2,2-disubstituted cyclic ether derivatives and hair tonics containing the same
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063190A1 New compounds, their preparation and use
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063172A1 N-substituted piperidine derivatives
10/26/2000WO2000063165A1 Mmp inhibitor
1 ... 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 ... 1065